Identification of novel oligodendroglioma‐associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray‐based expression profiling

Overview of attention for article published in International Journal of Cancer, June 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent: 4 patents

Readers on

mendeley: 26 Mendeley
connotea: 1 Connotea

Summary Patents

So far, Altmetric has seen 4 patents that reference this research output.

MEDICAMENT CONTAINING RECOMBINANT MISTLETOE LECTINS FOR THE TREATMENT OF BRAIN TUMORS

Application WO-2017140739-A1

World Intellectual Property Organisation (WIPO)

MEDICINE CONTAINING RECOMBINANT MISTELLECTINS FOR TREATING BRAIN TUMOURS

Application EP-3205348-A1

European Patent Office

Biomarker for the diagnosis of brain tumor

Application DE-102008011850-A1

Germany

BIOMARKER FOR THE DIAGNOSIS OF A BRAIN TUMOR

Application WO-2009106065-A2

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.